Sunnyvale, CA – Liquid chromatography analysis manufacturer Dionex Corporation says it has agreed to purchase ESA Biosciences’ high-performance liquid chromatograph (HPLC)-related products, HPLC clinical assays, laboratory services and assets.
This acquisition will add three HPLC detector families to the Dionex HPLC product portfolio: the Corona® family of universal charged aerosol detectors (CAD), and the CoulArray® and Coulochem® electrochemical detectors for the neuroscience, clinical, and metabolomics research applications.
“Dionex is dedicated to increasing our presence in life science applications as we see a large opportunity for future growth in this area,” said Dr Frank Witney, president and CEO of Dionex. “We are very excited about the addition of the Life Sciences Tools Business Unit of ESA Biosciences, its product lines and services to our HPLC product portfolio. ESA Biosciences has a distinguished history of innovation, especially with its proprietary Corona ultra detector that provides UHPLC capabilities, representing the first-inclass universal UHPLC detector”.
The transaction is expected to close by the end of September.